v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2026
Mar. 31, 2025
Current assets:    
Cash and cash equivalents $ 209,024 $ 111,119
Short-term investments 59,865 372,685
Research and development incentives receivable 1,619 3,725
Prepaid expenses and other current assets 8,611 8,351
Total current assets 279,119 495,880
Property, plant and equipment, net 12,974 13,739
Restricted cash 1,703 1,703
Other non-current assets 2,942 1,200
Right-of-use asset – operating leases 3,270 3,998
Right-of-use asset – finance leases 32,380 34,808
Total assets 332,388 551,328
Current liabilities:    
Accounts payable 6,671 12,463
Accrued expenses and other current liabilities 47,516 45,916
Operating lease liabilities, current 1,158 1,184
Finance lease liabilities, current 2,883 2,799
Total current liabilities 58,228 62,362
Operating lease liabilities, non-current 2,328 3,076
Finance lease liabilities, non-current 21,909 22,729
Long term debt, net of discount 83,308 46,377
Other liabilities, non-current 455 941
Total liabilities 166,228 135,485
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.001 par value; 150,000,000 shares authorized as of March 31, 2026 and March 31, 2025; 82,716,923 and 77,085,024 shares issued and outstanding as of March 31, 2026 and March 31, 2025, respectively 82 77
Additional paid-in capital 1,423,194 1,358,897
Accumulated deficit (1,262,519) (948,579)
Accumulated other comprehensive income 5,403 5,448
Total stockholders’ equity 166,160 415,843
Total liabilities and stockholders’ equity $ 332,388 $ 551,328